HAS opinions and decisions
La fiche de bon usage du médicament intitulée « Xolair (omalizumab) dans le traitement de l’asthme sévère», ci-jointe, est adoptée.
See also
HAS opinions and decisions
17/11/2017
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
PDMY6kvG0P9s59AV